AGLE - Aeglea BioTherapeutics EPS beats by $0.04 March, 18 2021 08:47 AM Aeglea BioTherapeutics Inc. Aeglea BioTherapeutics (AGLE): FY GAAP EPS of -$1.52 beats by $0.04.Cash, cash equivalents, marketable securities and restricted cash of $148.1MPress Release For further details see: Aeglea BioTherapeutics EPS beats by $0.04